Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,295
Sort by:

Toxoplasmosis R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Toxoplasmosis Pipeline Overview The Q4 Toxoplasmosis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

October 2020 30 pages

Tularaemia R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Tularaemia Pipeline Overview The Q4 Tularaemia pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for T...

October 2020 45 pages

Typhoid Fever R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Typhoid Fever Pipeline Overview The Q4 Typhoid Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

October 2020 61 pages

Vancomycin-Resistant Enterococcus faecium Infections R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Vancomycin-Resistant Enterococcus faecium Infections Pipeline Overview The Q4 Vancomycin-Resistant Enterococcus faecium Infections pipeline report is part of the VPA 110 Infectious Disease pipeline se...

October 2020 103 pages

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Pipeline Overview The Q4 Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline report is part of the VPA 110 Infectious Dis...

October 2020 61 pages

Ventilator Associated Pneumonia (VAP) R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Ventilator Associated Pneumonia (VAP) Pipeline Overview The Q4 Ventilator Associated Pneumonia (VAP) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review d...

October 2020 126 pages

Warts R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Warts Pipeline Overview The Q4 Warts pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Warts, prov...

October 2020 108 pages

West Nile Virus Infections R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

West Nile Virus Infections Pipeline Overview The Q4 West Nile Virus Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

October 2020 63 pages

Western Equine Encephalitis R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Western Equine Encephalitis Pipeline Overview The Q4 Western Equine Encephalitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipelin...

October 2020 30 pages

Yellow Fever R&D Pipeline Analysis Report, Q4 2020

US$ 1,699.00

Yellow Fever Pipeline Overview The Q4 Yellow Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development f...

October 2020 63 pages

Global Gummy Vitamins Market Size study, by Product Type (Single vitamin and Multivitamin), by Source (Plant and Animal), by Packaging Type (Bottles and jars and Pouches), by Distribution Channel (Store-based and Online), by End-Users (Adult and Children) and Regional Forecasts 2020-2027

US$ 3,750.00

Global Gummy Vitamins Market is valued approximately at USD 5.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2027. Gummy vitam...

October 2020 200 pages

Gummy Vitamins Market by Product Type (Multivitamins, Single Vitamins), Source (Animal, Plant), Packaging Type (Bottles & Jars, Pouches), Distribution Channel (Store-Based, Online), End User (Adult, Children), and Region - Global Forecast to 2025

US$ 4,950.00

According to MarketsandMarkets, the global gummy vitamins market size is estimated to be valued at USD 5.9 billion in 2020 and projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5%, i...

October 2020 194 pages

Vitamin D: Global Market Intelligence (2018-2028)

US$ 4,250.00

REPORT OBJECTIVES The report “Vitamin D Market: Global Market Intelligence (2018-2028) provides market intelligence on the different market segments, based on Market Dynamics, Distribution Channel, P...

September 2020 90 pages

Global Drug Screening Laboratory Services Market Size study, by Service Type (Workplace Drug Testing, Clinical Toxicology), by Sample Type (Urine Sample, Oral Fluid Sample, Hair Sample, Others), by End-User (Hospital Laboratories, Clinical Laboratories, Others) and Regional Forecasts 2020-2027

US$ 3,750.00

Global Drug Screening Laboratory Services Market is valued approximately at USD 6.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 202...

September 2020 200 pages

2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 2,399.00

Report Description The September updated COVID-19 clinical trials report presents a comprehensive 1800 page analysis on all clinical trials across 96 countries worldwide. The report provides phase wis...

September 2020 1800 pages

Global Migraine Drugs Market (by Mode of Administration, Treatment Class & Regions): Insights and Forecast with Potential Impact of COVID-19 (2020-2024)

US$ 1,700.00

The global migraine market is expected to reach US$5.10 billion in 2024, growing at a CAGR of 3.7%, for the duration spanning 2020-2024. The factors such as growing female population, increasing cigar...

September 2020 107 pages

COVID-19 Therapy and Vaccine Drug Pipeline Market Report- September 2020 Update

US$ 2,899.00

The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phase 3 and around 15 companies...

September 2020 512 pages

COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update

US$ 4,250.00

COVID-19 Pipeline Analysis The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phas...

September 2020 2300 pages

Acne Drugs: Global Markets

US$ 5,500.00

Report : This report offers a detailed picture of the acne drugs market. It highlights the current and future market potential for acne drugs and provides a detailed analysis of the competitive enviro...

September 2020 110 pages

177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigatio...

September 2020 50 pages

AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational pr...

September 2020 50 pages

ACE-536 (Luspatercept)- Drug Insight and Market Forecast – 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours “ACE-536 (Luspatercept)- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product ind...

September 2020 50 pages

AT845 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “AT845 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...

September 2020 50 pages

AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...

September 2020 50 pages

BERCOLAGENE TELSERPAVEC (KB103)- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BERCOLAGENE TELSERPAVEC (KB103)- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an in...

September 2020 50 pages

BLU 782- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BLU 782- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

DNX-2401 (Tasadenoturev) - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “DNX-2401 (Tasadenoturev) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investig...

September 2020 50 pages

EB 101- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “EB 101- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...

September 2020 50 pages

FCX-007- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “FCX-007- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

FLT190 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “FLT190 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

GARETOSMAB (REGN2477)- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “GARETOSMAB (REGN2477)- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigatio...

September 2020 50 pages

HC 1119- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “HC 1119- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

HORA-PDE6B - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “HORA-PDE6B - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational produc...

September 2020 50 pages

KB 105 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “KB 105 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

Lenti-D- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “Lenti-D- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

Onvansertib + Abiraterone- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “Onvansertib + Abiraterone- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investig...

September 2020 50 pages

PALOVAROTENE- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “PALOVAROTENE- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational produ...

September 2020 50 pages

RT 100 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “RT 100 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

Seviteronel- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “Seviteronel- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational produc...

September 2020 50 pages

SPK 3006 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “SPK 3006 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...

September 2020 50 pages

ST-920 - Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “ST-920 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages

Talimogene Laherparepvec- Drug Insight and Market Forecast – 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours “Talimogene Laherparepvec- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product i...

September 2020 50 pages

VB 111 (VBL Therapeutics)- Emerging Drug Insight and Market Forecast – 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “VB 111 (VBL Therapeutics)- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investig...

September 2020 50 pages

Zynteglo- Drug Insight and Market Forecast – 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours “Zynteglo- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the...

September 2020 50 pages

India Therapeutic Drug Monitoring Market By Product (Consumables, Equipment), By Technology (Immunoassays, Chromatography-Ms and Others), By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others), By End User (Hospital, Private Labs), By Region, Competition, Forecast & Opportunities, FY 2026

US$ 4,000.00

India therapeutic drug monitoring market is forecast to grow from an estimated $ 85 million in FY 2021 to $ 119 million by FY 2026 owing to the rising need of maintaining the drug levels in blood for...

September 2020 79 pages

Global DNA Damage Response Drugs Market: Focus on Commercialized Drugs, Potential Pipeline Drugs, Application, Country Data (13 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

US$ 2,500.00

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. Market Report Coverage - DNA Damage Response...

August 2020 247 pages

Acne Vulgaris pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Acne Vulgaris PIPELINE HIGHLIGHTS Acne Vulgaris is one of the widely researched conditions during 2020 with 42 companies actively focusing on realizing pipeline’s potential. Development of Acne V...

July 2020 210 pages

Acromegaly pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Acromegaly PIPELINE HIGHLIGHTS Acromegaly is one of the widely researched conditions during 2020 with 22 companies actively focusing on realizing pipeline’s potential. Development of Acromegaly m...

July 2020 96 pages

Actinic Keratosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Actinic Keratosis PIPELINE HIGHLIGHTS Actinic Keratosis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development o...

July 2020 59 pages

Filters

Search

Publishers

1
318
174
29
4
667
409
35
27
971
77
19
16
425
2
21
1
16
111
1
5
9
2,264
5
4
31
6
142
1
17
15
248
651
89
1
373
26
34
586
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
109
28
19
4
7
3
324
15
1
23
72
24
29
44
296
17
18
2

Regions

131
40
38
37
37
35
32
21
12
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
90
12
354
31
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
38
4
4
3
3
3
1
1
3
9
7,953

Price

Date

Pages

Offers

9
1